Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
For researchers

Methods, data and protocols — in full detail

Everything a formulation or delivery scientist needs to evaluate our platform: how we make and measure carriers, the protocols we use and the literature behind them.

Methodology

How we make and measure a carrier

  1. Step 1

    Design

    Ionisable lipid, helper lipid, cholesterol and PEG-lipid ratios chosen by design of experiments, not by habit.

  2. Step 2

    Formulate

    Microfluidic mixing at controlled total flow rate and flow-rate ratio, from 5 mL screening batches upwards.

  3. Step 3

    Characterise

    Size and PDI by DLS, zeta potential, encapsulation efficiency, cryo-TEM morphology and apparent pKa by TNS assay.

  4. Step 4

    Test

    Transfection, viability and uptake in relevant cell panels, then biodistribution with matched imaging labels.

See the mechanism animated on the technology page.

Technical specifications

BrilliantCore™ at a glance

Particle size range
12–80 nm
Polydispersity index
< 0.09
Encapsulation efficiency
96.4%
Batch scale
5 mL → 50 L
Storage stability
30 days @ 4 °C
Endotoxin
< 0.25 EU/mL
Protocols & tools

Run it in your own lab

Publications

Latest literature reviews

All articles →
Downloads

White papers & application notes

All downloads →
  • BrilliantCore™ platform technical briefPDF ↓
  • Engineering endosomal escape: design rules for ionisable lipid nanoparticlesPDF ↓
  • Targeting ligand selection for nanocarriersPDF ↓
  • Controlling LNP size and PDI with microfluidic mixingPDF ↓